Rifampicin and sodium fusidate reduces the frequency of methicillin-resistant Staphylococcus aureus (MRSA) isolation in adults with cystic fibrosis and chronic MRSA infection

Journal of Hospital Infection

Volumn 56, Issue 3, 2004, Pages 208-214

  Garske, L A ^a,c   Kidd, T J ^b   Gan, R ^a   Bunting, J P ^a   Franks, C A ^a   Coulter, C ^b   Masel, P J ^a,c   Bell, Scott C ^a,b,c  

^a Adult Cystic Fibrosis Unit   (Australia)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cystic fibrosis; MRSA; Rifampicin; Sodium fusidate

Indexed keywords

ANTIBIOTIC AGENT; ANTIEMETIC AGENT; BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; FUSIDATE SODIUM; GLYCOPEPTIDE; IMIPENEM; MEROPENEM; METICILLIN; METRONIDAZOLE; PSEUDOMONIC ACID; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; TIMENTIN; TOBRAMYCIN; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DIARRHEA; ENDEMIC DISEASE; ERADICATION THERAPY; FEMALE; FORCED EXPIRATORY VOLUME; GASTROINTESTINAL SYMPTOM; HOSPITAL INFECTION; HUMAN; INTERMETHOD COMPARISON; LUNG FUNCTION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NAUSEA; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; SPUTUM ANALYSIS; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; ANTI-BACTERIAL AGENTS; CARRIER STATE; CHRONIC DISEASE; CROSS INFECTION; CYSTIC FIBROSIS; FEMALE; FUSIDIC ACID; HUMANS; MALE; METHICILLIN RESISTANCE; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 1342286303     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2003.12.003     Document Type: Article

References (13)

1. Cystic Fibrosis Foundation Patient Registry Annual Data Report. 2000. Bethesda, MD: September 2001.
2. Boyce J.M. Methicillin-resistant Staphylococcus aureus in hospitals and long-term care facilities: microbiology, epidemiology, and preventive measures Infect Control Hosp Epidemiol 13 1992 725-737
3. Govan J.R.W. Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex J Roy Soc Med 93 Suppl. 38 2000 40-45
4. Maurer J.R. Frost A.E. Estenne M. Higenbottam T. Glanville A.R. International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society Transplantation 66 1998 951-956
5. Thomas S.R. Gyi K.M. Gaya H. Hodson M.E. Methicillin-resistant Staphylococcus aureus: impact at a national cystic fibrosis centre J Hosp Infect 40 1998 203-209
6. McCaffery K. Olver R.E. Franklin M. Mukhopadhay S. Systematic review of antistaphylococcal antibiotic therapy in cystic fibrosis Thorax 54 1999 380-383
7. Tenover F.C. Arbeit R.D. Goering R.V. et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field electrophoresis: criteria for bacterial strain typing J Clin Micro 33 1995 2233-2239
8. French G.L. Rao G. Gaya H. Hodson M. Meeting report MRSA in cystic fibrosis J Hosp Infect 40 1998 179-181
9. Kraemer R. Schaad U.B. Lebek G. Rudeberg A. Rossi E. Sputum penetration of fusidic acid in patients with cystic fibrosis Eur J Pediatr 138 1992 172-175
10. Kropec A. Dascher F.D. Penetration into tissues of various drugs active against Gram-positive bacteria J Antimicrobial Chem 27 Suppl. B 1991 9-15
11. Boxerbaum B. Jackobs M.R. Chechner R.I. Prevalence and significance of methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis Pediatr Pulmonol 4 1988 159-163
12. Miall L.S. McGinley N.T. Brownlee K.G. Conway S.P. Methicillin-resistant Staphylococcus aureus (MRSA) infection in cystic fibrosis Arch Dis Child 84 2001 160-162
13. Givney R. Vickery A. Holliday A. Pegler M. Benn R. Methicillin-resistant Staphylococcus aureus in a cystic fibrosis unit J Hosp Infect 35 1997 27-36